Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. MISOONE
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

MISOONE

Medicine - Posted on Sep 21 2021
Active substance (DCI)
  • misoprostol
history (4)
  • 9/8/21

    GYMISO - MISOONE (misoprostol)

    Recommandation pour la prise en charge d'une RTU Prise en charge des interruptions médicales de grossesses (IMG) et des cas ...
    icône flèche
  • 9/8/21

    GYMISO - MISOONE (misoprostol) / MIFEGYNE (mifépristone)

    Recommandation pour la prise en charge d'une RTU Prise en charge des grossesses arrêtées du premier trimestre (avant 14 SA)....
    icône flèche
  • 6/10/20

    MISOONE

    Key points Favourable opinion for reimbursement in cervix uteri preparation prior to surgical termination of pregnancy durin...
    CAV :
    54321
    icône flèche
  • 10/16/13

    MisoOne 400 µg (misoprostol), prostaglandine ocytocique

    Pas d’avantage clinique démontré dans le schéma thérapeutique de l’interruption volontaire de grossesse médicamenteuse MISOO...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • G02AD06
Manufacturer
NORDIC PHARMA
Presentation

MISOONE 400 microgrammes, comprimé (code CIS : 61240145)
plaquette(s) de 1 comprimé (CIP : 34009 274 266 8 1)
plaquette(s) de 16 comprimés (CIP : 34009 584 966 8 4)
plaquette(s) de 16 comprimés (CIP : 34009 584 964 5 5)

All our publications
    Contraception, abortion and sterilization Drug therapy

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
eNq1mFFv2jAQx9/5FFHeSQgr0E6BamPthtSqjII27aUyyQFmwU7PNoV9+jmEbqFK1Nbgx/ic/519559PDi83q8RZAwrKWdcNvIbrAIt4TNm8607G1/Vz97JXC5dkTQrTOl7DC5quEyVEiK6bWb0pECa8n7c3X0D/D+j2ak7Ip0uI5ME8JWnifSNicUvSbI4TrjmNnRXIBY+7bqrkbtQJhUQdRe+J42+RkghCfz9StC4fzorjoZ+JvUFVCcAbwualosCMNCOFCEz2iYQ5x21FvB+MtKkYgeAKIxgSuRgiX9MY4lIXM5IIMHIye4rvAdcJyMxJqbi/jFbCSJwsyWYEj4PyoD9pa19uZL1RDzqtZtC+aAXNTrtl5AoLW1WeBb0IP00xfmhenJ+dty98YP6KCs4ZGKZnyFGSxFJiqOgf1pYlPwiPrxZATEWakK23FKnpVhEk2gyoCWBvIdkKxqiZlOg9e6HPVJL474x6sieGpYgzIPW5YrICHNcj043ocyZhU51RM9bJzb4WKYjTyf55cQD/GYZqmtDIlGqaOwqEnIwG1VA7MQ8+EwETtAeEH5TF/EmcHjTFxFqKPt2xslRU5yDIktAOWi3jc/RLp63inrlSyFPwNYKoOIYsAzbjxzJFF2a51HNZnrIidw0Pj0gCFS1P3ZAwuhSfOzRrxW7vIOWGUtGvV2PTCvmuALf3u89SaRp3i7k1I7ANrOuSrIz9/QWen3Mr/bDCcn4spEzFR99fEFEXRO+QN0MbeC9cqvaacSs3d97J5Ii0FPo0v/veniDTc/bavX5sr7r/f98Tl/qQqOCIPORItgbOwdXpWfy/UbUW9vAAHPbc7JpKIilntjodNS1vc46lv04tu0bNh7vZjFa8jVSWZujn7zK9WuhnbzK92l8x7eoX
0hDrHpC12WQnD06h